2. Search Result
Search Result
Results for "

omega-3 fatty acid

" in MedChemExpress (MCE) Product Catalog:

53

Inhibitors & Agonists

8

Biochemical Assay Reagents

9

Natural
Products

8

Isotope-Labeled Compounds

1

Click Chemistry

1

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P2959
    Menhaden oil, crude source of omega-3 fatty acids

    Fish oil from menhaden, crude source of omega-3 fatty acids

    		 Biochemical Assay Reagents Others
    Menhaden oil, crude source of omega-3 fatty acids is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Menhaden oil, crude source of omega-3 fatty acids
  • HY-125139
    omega-3 Arachidonic acid ethyl ester, in ethanol, 98%

    ω-3 Arachidonic acid ethyl ester, in ethanol, 98%; (all-Z)-8,11,14,17-Eicosatetraenoic acid ethyl ester, in ethanol, 98%

    		 Biochemical Assay Reagents Cardiovascular Disease Others
    omega-3 Arachidonic acid ethyl ester, in ethanol, 98% is a rare polyunsaturated fatty acid found in very small amounts in dietary sources. Omega-3 fatty acids are known to be essential for the growth and development of infants, and they protect against heart disease, blood clots, high blood pressure, and inflammatory and autoimmune diseases. In human platelet membranes, omega-3 arachidonic acid inhibits arachidonyl-CoA synthetase with a Ki of 14 μM. It also inhibits arachidonoyl-CoA synthetase in calf brain extract with an IC50 of approximately 5 μM. Omega-3 ethyl arachidonate is the more lipophilic form of the free acid.
    omega-3 Arachidonic acid ethyl ester, in ethanol, 98%
  • HY-B0660S
    Eicosapentaenoic Acid-d5

    EPA-d5; Timnodonic acid-d5

    		 Endogenous Metabolite Histone Demethylase Neurological Disease Cancer
    Eicosapentaenoic Acid-d5 is the deuterium labeled Eicosapentaenoic Acid. Eicosapentaenoic Acid (EPA; Timnodonic acid) is an omega-3 fatty acid.
    Eicosapentaenoic Acid-d5
  • HY-B2167
    Docosahexaenoic acid
    Maximum Cited Publications
    31 Publications Verification

    DHA; Cervonic acid

    		 Endogenous Metabolite Neurological Disease Cancer
    Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
    Docosahexaenoic acid
  • HY-154632
    Omega 3 fatty acid triglycerides

    		Biochemical Assay Reagents Others
    Omega 3 fatty acid triglycerides can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs .
    Omega 3 fatty acid triglycerides
  • HY-124089
    Eicosapentaenoyl ethanolamide

    		Cannabinoid Receptor Metabolic Disease
    Eicosapentaenoyl ethanolamide, an omega-3 fatty acid, is one of N-acylethanolamines (NAEs). Eicosapentaenoyl ethanolamide is cannabinoid CB1/CB2 receptor agonist. Eicosapentaenoyl ethanolamide acts as a metabolic signal. Eicosapentaenoyl ethanolamide inhibits dietary restriction (DR)-induced lifespan extension in wild type animals and suppresses lifespan extension in a TOR pathway mutant .
    Eicosapentaenoyl ethanolamide
  • HY-B0747S
    Eicosapentaenoic acid ethyl ester-d5

    		Endogenous Metabolite Metabolic Disease
    Eicosapentaenoic acid ethyl ester-d5 is the deuterium labeled Eicosapentaenoic acid ethyl ester. Eicosapentaenoic acid ethyl ester is an omega-3 fatty acid agent.
    Eicosapentaenoic acid ethyl ester-d5
  • HY-115437
    Methyl all-cis-7,10,13,16,19-docosapentaenoate

    		Biochemical Assay Reagents Others
    Methyl all-cis-7,10,13,16,19-docosapentaenoate is a long-chain polyunsaturated omega-3 fatty acid esters.
    Methyl all-cis-7,10,13,16,19-docosapentaenoate
  • HY-B0747R
    Eicosapentaenoic acid ethyl ester (Standard)

    EPA ethyl ester(Standard); Ethyl eicosapentaenoate (Standard); AMR101 (Standard)

    		 Endogenous Metabolite Metabolic Disease
    Eicosapentaenoic acid ethyl ester (Standard) is the analytical standard of Eicosapentaenoic acid ethyl ester. This product is intended for research and analytical applications. Eicosapentaenoic acid ethyl ester is an omega-3 fatty acid agent.
    Eicosapentaenoic acid ethyl ester (Standard)
  • HY-120978
    Omega-3 arachidonic acid methyl ester

    ω-3 Arachidonic acid methyl ester; (all-Z)-8,11,14,17-Eicosatetraenoic acid methyl ester

    		 Biochemical Assay Reagents Others
    omega-3 Arachidonic Acid methyl ester, mainly docosahexaenoic acid, eicosapentaenoic acid and α-Linoleic acid, represented by linoleic acid, is an essential dietary nutrient required for normal growth and development.Omega-3Methyl arachidonic acid is a rare fatty acid Omega-3Neutral fat-soluble form of arachidonic acid. Omega-3Fatty acids, as a group, were associated with reduced inflammation and autoimmune activity, as well as reduced thrombosis and platelet activation.
    Omega-3 arachidonic acid methyl ester
  • HY-165078
    (±)11(12)-EpETE

    (±)11,12-EEQ; (±)11,12-Epoxyeicosatetraenoic acid

    		 Endogenous Metabolite Others
    (±)11(12)-EpETE ((±)11,12-EEQ) is an EPA hydroxyl product. EPA is a major component of Omega-3 polyunsaturated fatty acids (PUFAs) .
    (±)11(12)-EpETE
  • HY-B2167S
    Docosahexaenoic acid-d5

    DHA-d5; Cervonic acid-d5

    		 Endogenous Metabolite Neurological Disease
    Docosahexaenoic acid-d5 is the deuterium labeled Docosahexaenoic Acid. Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.
    Docosahexaenoic acid-d5
  • HY-B2167S2
    Docosahexaenoic acid-13C4

    		Isotope-Labeled Compounds Endogenous Metabolite Neurological Disease Cancer
    Docosahexaenoic acid- 13C4 is 13C labeled Docosahexaenoic acid. Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk .
    Docosahexaenoic acid-13C4
  • HY-170473
    Wheat germ oil

    		Biochemical Assay Reagents Others
    Wheat germ oil is an oil with nutritional value, especially its high Vitamin E content. Wheat germ oil is rich in health- beneficial bioactive compounds, such as phytosterols, tocopherols, carotenoids, and omega-3 fatty acids .
    Wheat germ oil
  • HY-N7833
    Heneicosapentaenoic acid

    		Biochemical Assay Reagents Others
    Heneicosapentaenoic Acid (HPA) is a 21:5 omega-3 fatty acid found in trace amounts in the green alga B. pennata and in fish oils. Its chemical composition is similar to eicosapentaenoic acid (EPA), except that a carbon is extended at the carboxy terminus, placing the first double bond at the δ6 position. HPA can be used to study the importance of double bond position in omega-3 fatty acids. It incorporates phospholipids and triacylglycerols in vivo with the same efficiency as EPA and docosahexaenoic acid, and exhibits a strong inhibitory effect on the synthesis of arachidonic acid from linoleic acid. HPA is a poor substrate for prostaglandin H synthase (PGHS) (cyclooxygenase) and 5-lipoxygenase, but retains the ability to rapidly inactivate PGHS.
    Heneicosapentaenoic acid
  • HY-115369
    Methyl (13Z,16Z,19Z)-docosatrienoate

    		Biochemical Assay Reagents Others
    cis-13,16,19-Docosatrienoic acid methyl ester is an ester form of docosatrienoic acid, a rare omega-3 fatty acid not found in the normal phospholipid polyunsaturated fatty acid pool Easily detectable, it inhibits the binding of [3H]-LTB4 to porcine neutrophils at a concentration of 5 μM. Methyl docosatrienoate is more fat-soluble than the free acid and may be more desirable than the free acid in some formulations.
    Methyl (13Z,16Z,19Z)-docosatrienoate
  • HY-120987
    Ethyl stearidonate

    		Biochemical Assay Reagents Others
    6,9,12,15-octadecatetraenoic acid (Glycerol α-monoelaidate) is a rare omega-3 series polyunsaturated fatty acid. In normal people, it accounts for less than 0.25% of serum phospholipid fatty acids. It is found in certain natural oils, such as echium and blackcurrant, and to the extent that these oils are incorporated into nutraceuticals, stearidonic acid can be an important polyunsaturated species in the human diet. Ethyl stearidonic acid, an ester of the free acid, is less water soluble but more suitable for formulating stearidonic acid-containing diets and dietary supplements.
    Ethyl stearidonate
  • HY-W011269
    Eicosapentaenoic Acid sodium

    EPA sodium; Timnodonic acid sodium

    		 Endogenous Metabolite Histone Demethylase Cardiovascular Disease Metabolic Disease Cancer
    Eicosapentaenoic Acid (EPA)sodium is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic Acid sodium exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid sodium activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic Acid sodium can promote relaxation of vascular smooth muscle cells and vasodilation .
    Eicosapentaenoic Acid sodium
  • HY-B0660
    Eicosapentaenoic Acid
    15+ Cited Publications

    EPA; Timnodonic acid

    		 Endogenous Metabolite Histone Demethylase Neurological Disease Cancer
    Eicosapentaenoic Acid (EPA) is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic Acid exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic Acid can promote relaxation of vascular smooth muscle cells and vasodilation .
    Eicosapentaenoic Acid
  • HY-B0660A
    Eicosapentaenoic acid (metformin)

    EPA (metformin); Timnodonic acid (metformin)

    		 Endogenous Metabolite Histone Demethylase Neurological Disease Cancer
    Eicosapentaenoic Acid (EPA) metformin is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic acid metformin exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). EEicosapentaenoic acid metformin activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic acid metformin can promote relaxation of vascular smooth muscle cells and vasodilation .
    Eicosapentaenoic acid (metformin)
  • HY-124089S
    Eicosapentaenoyl ethanolamide-d4

    		Isotope-Labeled Compounds Cannabinoid Receptor Metabolic Disease
    Eicosapentaenoyl ethanolamide-d4 is the deuterium labeled Eicosapentaenoyl ethanolamide. Eicosapentaenoyl ethanolamide, an omega-3 fatty acid, is one of N-acylethanolamines (NAEs). Eicosapentaenoyl ethanolamide is cannabinoid CB1/CB2 receptor agonist. Eicosapentaenoyl ethanolamide acts as a metabolic signal. Eicosapentaenoyl ethanolamide inhibits dietary restriction (DR)-induced lifespan extension in wild type animals and suppresses lifespan extension in a TOR pathway mutant[1][2].
    Eicosapentaenoyl ethanolamide-d4
  • HY-B0660R
    Eicosapentaenoic Acid (Standard)

    		Endogenous Metabolite Histone Demethylase Neurological Disease Cancer
    Eicosapentaenoic Acid (Standard) is the analytical standard of Eicosapentaenoic Acid. This product is intended for research and analytical applications. Eicosapentaenoic Acid (EPA) is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic Acid exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic Acid can promote relaxation of vascular smooth muscle cells and vasodilation .
    Eicosapentaenoic Acid (Standard)
  • HY-B0660S1
    Eicosapentaenoic acid 1,2,3,4,5-13C5

    EPA 1,2,3,4,5-13C, FA 20:5-13C5

    		 Isotope-Labeled Compounds Endogenous Metabolite Histone Demethylase Neurological Disease Cancer
    Eicosapentaenoic acid 1,2,3,4,5- 13C5 (EPA 1,2,3,4,5- 13C, FA 20:5- 13C5) is 13C labeled Eicosapentaenoic Acid. Eicosapentaenoic Acid (EPA) is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic Acid exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic Acid can promote relaxation of vascular smooth muscle cells and vasodilation .
    Eicosapentaenoic acid 1,2,3,4,5-13C5
  • HY-114041
    Resolvin E1
    2 Publications Verification

    RvE1

    		 Endogenous Metabolite Inflammation/Immunology
    Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production .
    Resolvin E1
  • HY-B0747
    Eicosapentaenoic acid ethyl ester

    EPA ethyl ester; Ethyl eicosapentaenoate; AMR101

    		 Endogenous Metabolite Metabolic Disease
    Eicosapentaenoic acid ethyl ester (EPA ethyl ester) is an orally active ω-3 fatty acid agent. Eicosapentaenoic acid ethyl ester could improve the activity of liver β-oxidase in vitro, reduce the level of liver total triglyceride, increase the content of liver triglyceride and phospholipid ω-3 fatty acid, and increase the total ω-3 fatty acid level in rats .
    Eicosapentaenoic acid ethyl ester
  • HY-17639
    Navamepent

    RX-10045

    		 Biochemical Assay Reagents Inflammation/Immunology
    Navamepent is an analog of naturally occurring resolvin E1 (a major dietary omega-3 polyunsaturated fatty-acid metabolite) with potent anti-inflammatory and cell survival benefits. Navamepent is highly effective against dry eye and goblet cell loss thereby accelerating tear production. Also, Navamepent can reduce corneal inflammation, epithelial damage, and accelerate corneal tissue repair. In addition, Navamepent can inhibit the release of several key proinflammatory mediators from corneal epithelial cells. Navamepent is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    Navamepent
  • HY-114041S1
    Resolvin E1-d4-1

    RvE1-d4-1

    		 Endogenous Metabolite Inflammation/Immunology
    Resolvin E1-d4-1 is the deuterium labeled Resolvin E1. Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production[1][2].
    Resolvin E1-d4-1
  • HY-114041S
    Resolvin E1-d4

    RvE1-d4

    		 Isotope-Labeled Compounds Endogenous Metabolite Inflammation/Immunology
    Resolvin E1-d4 (RvE1-d4) is deuterium labeled Resolvin E1. Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production .
    Resolvin E1-d4
  • HY-101408
    Docosatrienoic Acid

    cis-13,16,19-docosatrienoic acid; (13Z,16Z,19Z)-13,16,19-Docosatrienoic acid

    		 Endogenous Metabolite Cardiovascular Disease
    Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM.
    Docosatrienoic Acid
  • HY-124355
    4-Hydroxy hexenal

    4-HHE

    		 Endogenous Metabolite Metabolic Disease
    4-Hydroxy hexenal (4-HHE) is a lipid peroxidation product derived from oxidized ω-3 fatty acids such as DHA.
    4-Hydroxy hexenal
  • HY-125140
    ω-3 Arachidonic acid

    		Endogenous Metabolite Others
    ω-3 Arachidonic acid is a poly fatty acid that is essential for growth and development in infants. ω-3 Arachidonic acid inhibits arachidenol-CoA synthetase with Ki values of 14 µM. It also inhibited arachidenol-CoA synthetase of calf brain extract with IC50 values of about 5 µM .
    ω-3 Arachidonic acid
  • HY-CE00116
    (11Z,14Z,17Z)-Icosatrienoyl-CoA

    C20:3(omega-3)-CoA; Cis-(omega-3)-icosatrienoyl-CoA

    		 Biochemical Assay Reagents Others
    (11Z,14Z,17Z)-Icosatrienoyl-CoA (C20:3(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (11Z,14Z,17Z)-Icosatrienoyl-CoA
  • HY-CE00023
    (12Z,15Z,18Z,21Z)-Tetracosatetraenoyl-CoA

    C24:4(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (12Z,15Z,18Z,21Z)-Tetracosatetraenoyl-CoA (C24:4(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (12Z,15Z,18Z,21Z)-Tetracosatetraenoyl-CoA
  • HY-CE00060
    (13Z,16Z,19Z)-3-Oxodocosatrienoyl-CoA

    3-Oxo-C22:3(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (13Z,16Z,19Z)-3-Oxodocosatrienoyl-CoA (3-Oxo-C22:3(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (13Z,16Z,19Z)-3-Oxodocosatrienoyl-CoA
  • HY-CE00015
    (11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA

    C26:5(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA (C26:5(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA
  • HY-CE00062
    (17Z,20Z,23Z,26Z,29Z)-Dotriacontapentaenoyl-CoA

    C32:5(omega-3)-coenzyme A

    		 Biochemical Assay Reagents Others
    (17Z,20Z,23Z,26Z,29Z)-Dotriacontapentaenoyl-CoA (C32:5(Omega-3)-coenzyme A) is an unsaturated fatty acyl-CoA.
    (17Z,20Z,23Z,26Z,29Z)-Dotriacontapentaenoyl-CoA
  • HY-CE00075
    (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA

    C28:5(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA (C28:5(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA
  • HY-CE00018
    (12Z,15Z,18Z,21Z)-3-Oxotetracosatetraenoyl-CoA

    3-Oxo-C24:4(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (12Z,15Z,18Z,21Z)-3-Oxotetracosatetraenoyl-CoA (3-Oxo-C24:4(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (12Z,15Z,18Z,21Z)-3-Oxotetracosatetraenoyl-CoA
  • HY-CE00033
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA

    C30:6(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA (C30:6(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA
  • HY-CE00101
    (14Z,17Z,20Z,23Z,26Z,29Z)-Dotriacontahexaenoyl-CoA

    C32:6(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (14Z,17Z,20Z,23Z,26Z,29Z)-Dotriacontahexaenoyl-CoA (C32:6(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (14Z,17Z,20Z,23Z,26Z,29Z)-Dotriacontahexaenoyl-CoA
  • HY-CE00047
    (16Z,19Z,22Z,25Z,28Z,31Z)-Tetratriacontahexaenoyl-CoA

    C34:6(omega-3)-coenzyme A

    		 Biochemical Assay Reagents Others
    (16Z,19Z,22Z,25Z,28Z,31Z)-Tetratriacontahexaenoyl-CoA (C34:6(Omega-3)-coenzyme A) is an unsaturated fatty acyl-CoA.
    (16Z,19Z,22Z,25Z,28Z,31Z)-Tetratriacontahexaenoyl-CoA
  • HY-CE00045A
    (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA

    C28:6(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA (C28:6(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA
  • HY-CE00071
    (13Z,16Z,19Z,22Z,25Z)-3-Oxooctacosapentaenoyl-CoA

    3-Oxo-C28:5(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (13Z,16Z,19Z,22Z,25Z)-3-Oxooctacosapentaenoyl-CoA (3-Oxo-C28:5(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (13Z,16Z,19Z,22Z,25Z)-3-Oxooctacosapentaenoyl-CoA
  • HY-CE00014
    (11Z,14Z,17Z,20Z,23Z)-3-Oxohexacosapentaenoyl-CoA

    3-Oxo-C26:5(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (11Z,14Z,17Z,20Z,23Z)-3-Oxohexacosapentaenoyl-CoA (3-Oxo-C26:5(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (11Z,14Z,17Z,20Z,23Z)-3-Oxohexacosapentaenoyl-CoA
  • HY-W783623
    1,3-Didocosahexaenoyl glycerol

    DG(22:6/0:0/22:6); 1,3-Didocosahexaenoin

    		 Biochemical Assay Reagents Cardiovascular Disease
    1,3-Didocosahexaenoyl glycerol (DG(22:6/0:0/22:6); 1,3-Didocosahexaenoin) is an ω-3 polyunsaturated fatty acid, which exhibits cardioprotective effects in rat myocardial ischemia/reperfusion (I/R) injury model through conjugation with Poly-l-glutamic acid (PGA) .
    1,3-Didocosahexaenoyl glycerol
  • HY-W718383
    7(Z),10(Z),13(Z)-Hexadecatrienoic acid

    Roughanic acid

    		 Drug Intermediate Others
    7(Z),10(Z),13(Z)-Hexadecatrienoic acid (Roughanic acid) is an ω-3 polyunsaturated fatty acid (PUFA) that can be found in the leaves of S. olusatrum. 7(Z),10(Z),13(Z)-Hexadecatrienoic acid is an intermediate in the biosynthesis of jasmonic acid .
    7(Z),10(Z),13(Z)-Hexadecatrienoic acid
  • HY-B2167R
    Docosahexaenoic acid (Standard)

    		Endogenous Metabolite Neurological Disease Cancer
    Docosahexaenoic acid (Standard) is the analytical standard of Docosahexaenoic acid. This product is intended for research and analytical applications. Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk. In Vitro: Docosahexaenoic acid (DHA) is essential for the growth and functional development of the brain in infants. DHA is also required for maintenance of normal brain function in adults. The inclusion of plentiful DHA in the diet improves learning ability and memory . DHA is an essential requirement in every step of brain development like neural cell proliferation, migration, differentiation, synaptogenesis. The multiple double bonds and unique structure allow DHA to impart special membrane characteristics for effective cell signaling. Many development disorders like dyslexia, autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia etc. are causally related to decreased level of DHA . DHA is a potent RXR ligand inducing robust RXR activation already at low micro molar concentrations. The EC50 for RXRα activation by DHA is about 5-10 μM fatty acid . In Vivo: Docosahexaenoic acid administration over 10 weeks significantly reduces the number of reference memory errors, without affecting the number of working memory errors, and significantly increases the docosahexaenoic acid content and the docosahexaenoic acid/arachidonic acid ratio in both the hippocampus and the cerebral cortex . DHA treatment exerts neuroprotective actions on an experimental mouse model of PD. There is a decrease tendency in brain lipid oxidation of MPTP mice but it does not significantly .
    Docosahexaenoic acid (Standard)
  • HY-CE00078
    (18Z,21Z,24Z,27Z,30Z,33Z)-3-Oxohexatriacontahexaenoyl-CoA

    3-Oxo-C36:6(omega-3)-coenzyme A

    		 Biochemical Assay Reagents Others
    (18Z,21Z,24Z,27Z,30Z,33Z)-3-Oxohexatriacontahexaenoyl-CoA (3-Oxo-C36:6(Omega-3)-coenzyme A) is an unsaturated fatty acyl-CoA.
    (18Z,21Z,24Z,27Z,30Z,33Z)-3-Oxohexatriacontahexaenoyl-CoA
  • HY-CE00097
    (14Z,17Z,20Z,23Z,26Z,29Z)-3-Oxodotriacontahexaenoyl-CoA

    3-Oxo-C32:6(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (14Z,17Z,20Z,23Z,26Z,29Z)-3-Oxodotriacontahexaenoyl-CoA (3-Oxo-C32:6(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (14Z,17Z,20Z,23Z,26Z,29Z)-3-Oxodotriacontahexaenoyl-CoA
  • HY-121212
    Icosabutate

    		Aminotransferases (Transaminases) Metabolic Disease Inflammation/Immunology
    Icosabutate, an orally active ω-3 polyunsaturated fatty acid, is an aeicosapentaenoic acid (EPA) derivative. Icosabutate overcomes the drawbacks of unmodified EPA for liver targeting and improves insulin sensitivity, hepatic inflammation and fibrosis . Icosabutate is well tolerated, and efficacious in lowering non-high-density lipoprotein cholesterol (non-HDL-C) levels in persistent?hypertriglyceridemia? .
    Icosabutate

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: